摘要:
The present invention relates to a method for treating pain, reflex sympathetic dystrophy, spasticity, and bipolar disorder using ligands of the α2δ voltage-gated calcium channel, wherein the ligand comprises (2s)-aminophenyl acetic acid and derivatives.
摘要:
The present invention relates to compounds of formula (I-VII) or a pharmaceutically acceptable salt or prodrug thereof, in which A, L, R6, R7 and R8 are defined herein. The present invention also relates to methods of treating pain using these compounds and pharmaceutical compositions including these compounds.
摘要:
Compounds having formula (I) or a pharmaceutically acceptable salt, prodrug, or salt of a prodrug thereof, wherein L, A, G, R1, R2 and R3 are as defined herein. These compounds are particularly useful in the treatment of pain, inflammatory hyperalgesia, and urinary dysfunctions, such as bladder overactivity and urinary incontinence.
摘要:
Compounds that are antagonists of the VR1 receptor, having formula (I) or a pharmaceutically acceptable salt, prodrug, or salt of a prodrug thereof, wherein A1, A2, A3, A4, R7, R8, R9, X, Y, Z, L, n, and m, are as defined herein, and are useful in disorders prevented or ameliorated by inhibiting the VR1 receptor.
摘要翻译:作为VR1受体的拮抗剂的化合物,具有式(I)或其药学上可接受的盐,前药或其前体药物的盐,其中A 1,A 2, A 3,S 4,R 7,R 8,R 9, X,Y,Z,L,n和m如本文所定义,并且可用于通过抑制VR1受体而防止或改善的病症。
摘要:
The present invention relates to compounds of formula (I) that are novel VR1 antagonists useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence, or bladder overactivity.
摘要:
The present invention relates to compounds of formula (I) that are novel VR1 antagonists useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence, or bladder overactivity.
摘要:
Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence, or bladder overactivity.
摘要:
The present invention relates to a method of treating disorders associated with the α2δ voltage-gated calcium channel ligand, comprising the administration of compounds of formula (I), or a pharmaceutically acceptable salt, amide, ester, or prodrug thereof.
摘要:
One exemplary signal amplification circuit used for processing an input signal includes an input stage, a plurality of output stages, and a selecting stage. The input stage has an input node for receiving the input signal and an output node for outputting an intermediate signal. The output stages are coupled to a plurality of output ports of the signal amplification circuit, respectively. Each of the output stages generates a corresponding processed signal to a corresponding output port according to a gain and a signal derived from the intermediate signal of the input stage when enabled. The selecting stage is arranged for selectively coupling the output node of the input stage to at least one of the output stages.